|
mean (standard deviation)
|
mean (standard deviation)
| | |
Duration of symptoms (months)
|
68.0 (69.8)
|
70.9 (75.0)
|
0.2737
|
4.03
|
Age (years)
|
67.2 (9.7)
|
66.4 (10.0)
|
0.0344
|
7.81
|
BMI (kg.m −2)
|
27.8 (4.9)
|
27.7 (4.7)
|
0.3824
|
3.14
|
Patient global assessment (0-100)
|
61.1 (18.2)
|
56.7 (17.4)
|
< 0.0001
|
24.44
|
Pain evaluation VAS (0-100)
|
59.4 (16.0)
|
55.3 (15.1)
|
< 0.0001
|
26.32
|
WOMAC function score (0-100)
|
45.5 (16.3)
|
43.8 (16.0)
|
0.0050
|
10.32
|
|
n (%)
|
n (%)
| | |
Osteoarthritis in other joints
|
1366 (91.4)
|
1311 (89.7)
|
0.1297
|
5.81
|
Prior treatment
| | | | |
IA treatment
|
434 (29.0)
|
432 (29.6)
|
0.7877
|
1.14
|
NSAIDs
|
955 (63.9)
|
958 (65.5)
|
0.3689
|
3.45
|
SYSADOA
|
617 (41.3)
|
605 (41.4)
|
0.9810
|
0.22
|
Male
|
424 (28.4)
|
459 (31.4)
|
0.0782
|
6.65
|
Kellgren and Lawrence grade
| | |
0.2594
| |
III
|
724 (48.4)
|
677 (46.3)
| |
4.25
|
IV
|
516 (34.5)
|
547 (37.4)
| |
6.02
|